Therapeutic delivery of mRNA: The medium is the message

Molecular Therapy

Volumn 19, Issue 5, 2011, Pages 822-823

  McIvor, R Scott ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; SURFACTANT PROTEIN B;

CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DNA INTEGRATION; DNA MODIFICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; LUNG DISEASE; NONHUMAN; NOTE; RNA INTERFERENCE; RNA SEQUENCE; RNA TRANSCRIPTION; SURFACTANT PROTEIN B DEFICIENCY; SURVIVAL TIME;

EID: 79955628258     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.67     Document Type: Note

References (17)

1. Kormann, MS, Hasenpusch, G, Aneja, MK, Nica, G, Flemmer, AW, Herber-Jonat, S et al. (2011). Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29: 154-157.
2. Hannon, GJ and Rossi, JJ (2004). Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378. (Pubitemid 39265678)
3. Weide, B, Pascolo, S, Scheel, B, Derhovanessian, E, Pflugfelder, A, Eigentler, TK et al. (2009). Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. J Immunother 32: 498-507.
4. Cannon, G and Weissman, D (2002). RNA based vaccines. DNA Cell Biol 21: 953-961. (Pubitemid 36126698)
5. Kawai, T and Akira, S (2010). The role of patternrecognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
6. Brennan, K and Bowie, AG (2010). Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 13: 503-507.
7. Kariko, K, Buckstein, M, Ni, H and Weissman, D (2005). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23: 165-175. (Pubitemid 41169286)
8. Liu, F, Song, Y and Liu, D (1999). Hydrodynamicsbased transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266. (Pubitemid 29359019)
9. Zhang, G, Budker, V and Wolff, JA (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10: 1735-1737. (Pubitemid 29328217)
10. Zhang, G, Wooddell, DI, Hegge, JO, Griffin, JB, Huss, T, Braun, S et al. (2010). Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection. Hum Gene Ther 21: 221-237.
11. Score, PR, Belur, LR, Frandsen, JL, Geurts, JL, Yamaguchi, T, Somia, NV et al. (2006). Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. Mol Ther 13: 617-624. (Pubitemid 43257630)
12. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, Mc- Cormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419. (Pubitemid 37296260)
13. Qasim, W, Gaspar, HB and Thrasher, AJ (2009). Progress and prospects: gene therapy for inherited immunodeficiencies. Gene Ther 16: 1285-1291.
14. Warren, L, Manos, PD, Ahfeldt, T, Loh, Y-H, Li, H, Lau, F et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.
15. Wilber, A, Frandsen, JL, Geurts, JO, Largaespada, DA, Hackett, PB, McIvor, RS (2006). RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Mol Ther 13: 625-639.
16. Wilber, A, Wangensteen, KJ, Chen, Y, Zhuo, L, Frandsen, JO, Bell, JB et al. (2007). Messenger RNA as a source of transposase for Sleeping Beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther 15: 1280-1287. (Pubitemid 46965324)
17. Urnov, FD, Rebar, EJ, Holmes, MC, Zhang, HS and Gregory, PD (2010). Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11: 636-646.